Yves Chalandon
GROUP LEADER
Department of Internal Medicine
Nephrogenex
Hungary
Biography
Area of clinical research on leukemia An area of research of the work group is the investigation of new treatments for the management of leukemia or hematologic malignancies patients. This group is involved in multicenter protocols phase I-III both national and international for the management of patients with acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, myelodysplastic syndrome, myeloproliferative neoplasia, lymphoproliferative neoplasia. Yves Chalandon is the principal investigator (PI) of a multicenter phase III study on acute lymphoblastic leukemia Philadelphia positive (GRAAPH 2014) and recently published the results of the previous GRAAPH 2005 for which he was also the PI (Chalandon et al. Blood 2015; 125: 3711). The group works in collaboration with the Clinical Research Unit of the HDFDL in the oncology center for the promotion of clinical research of patients with hematological malignancies and provides a platform for new therapies to patients in the Swiss French-speaking area suffering from these diseases. The group collaborates with the leukemia group and the lymphoma group of the SAKK (Swiss Cancer Research Group) and participates in the protocols of the latter.
Research Interest
Nephrology
